Abstract

Recently, we reported that cigarette smoking, and especially nicotine, increases susceptibility to mycobacterial infection and exacerbates inflammation in patients with Crohn’s disease (CD). The macrophagic response to Mycobacterium avium subspecies paratuberculosis (MAP) in CD and Mycobacteria tuberculosis (MTB) continues to be under investigation. The role of toll-like-receptors (TLRs) and cytoplasmic adaptor protein (MyD88) in proinflammatory response during Mycobacterial infection has been suggested. However, the mechanism of how nicotine modulates macrophage response during infection in CD and exacerbates inflammatory response remain unclear. In this study, we elucidated the mechanistic role of nicotine in modulating MyD88-dependent/TLR pathway signaling in a macrophage system during mycobacterial infection. The data demonstrated that MAP infection in THP-1 derived macrophages was mediated through TLR2 and MyD88 leading to increase in IL-8 in expression and production. On the other hand, LPS-representing, Gram-negative bacteria mediated macrophage response through TLR4. Blocking TLR2 and TLR4 with antagonists voided the effect of MAP, and LPS, respectively in macrophages and reversed response with decrease in expression of iNOS, TNF-α and IL-8. Interestingly, nicotine in infected macrophages significantly (1) downregulated TLR2 and TLR4 expression, (2) activated MyD88, (3) increased M1/M2 ratio, and (4) increased expression and secretion of proinflammatory cytokines especially IL-8, as seen in CD smokers. We also discovered that blocking macrophages during MAP infection with MyD88 antagonist significantly decreased response which illustrates the key role for MyD88 during infection. Surprisingly, dual treatment of MAP-infected macrophages with MyD88 antagonist and nicotine absolutely impaired immune response and decreased MAP viability, which clearly validate the inflammatory role of nicotine in macrophages through TLR2/MyD88 pathway during infection. This is the first report to describe the mechanism by which nicotine modulates TLR2/MyDD88 and exacerbates inflammation in CD smokers associated with infection.

Highlights

  • Crohn’s Disease (CD) is one of the relapsing chronic diseases that affects the gastrointestinal tract

  • We discovered that blocking macrophages during Mycobacterium avium subspecies paratuberculosis (MAP) infection with myeloid differentiation primary response 88 (MyD88) antagonist significantly decreased response which illustrates the key role for MyD88 during infection

  • toll-like receptors (TLRs) are found in most mammals and each of them has specific transmembrane proteins with their own recognition patterns [7].While most TLRs are located on the cell surface, which plays an important role in recognition of microbial derivatives, TLR3, TLR7, and TLR9 are localized in the endosomes and bind mainly to microbial nucleic acids [8,9]

Read more

Summary

Introduction

Crohn’s Disease (CD) is one of the relapsing chronic diseases that affects the gastrointestinal tract. Despite the new findings by this group, there is a big gap in the literature about how nicotine modulates macrophage recognition patterns including TLRs and MyD88 signaling during mycobacterial infection. It is not understood how nicotine affects MAP recognition and infection in macrophages causing further inflammation and worsening symptoms in CD smokers. This study is focused on the elucidation of the mechanistic role of nicotine in modulating TLR and the MyD88-dependent signaling pathway in MAP-infected macrophages. We investigated the interplay between nicotine, TLR2 and TLR4 for their reported role in infection by gram-negative and -positive bacterial infection, and subsequent effect on MyD88 signaling, inflammatory response, and bacterial load in infected macrophages

Culture Conditions of THP-1 Macrophages
Infection and Treatment of THP-1 Macrophages
Measurement of Cell Receptors
MAP Viability Assay
Statistical Analysis
Results
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call